Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Completed 6

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 6Pain 1Neoplasm Metastasis 1

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Radium-223 × Genitourinary × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04037358 2025-12-19

RAVENS

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
64 enrolled 25 charts
Genitourinary

Prostatic Neoplasms

NCT03093428 2025-03-28

Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC

Dana-Farber Cancer Institute

Phase 2 Completed
45 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT03002220 2024-12-11

EXCAAPE

MedSIR

Phase 2 Completed
52 enrolled 15 charts
Genitourinary

Prostatic Neoplasms

NCT02278055 2023-04-07

Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Genitourinary

Pain, Prostatic Neoplasms

NCT02463799 2021-07-08

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
36 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡